Xining, China

Wenjing Jia

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chinese Academy of Sciences. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenjing Jia. Retrieved from https://idiyas.com/inventor/wenjing-jia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wenjing Jia: Innovator in Pharmaceutical Preparations

Introduction

Wenjing Jia is a notable inventor based in Xining, China. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of medicaments that enhance drug delivery across the blood-brain barrier.

Latest Patents

Wenjing Jia holds a patent for the "Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross blood-brain barrier." This invention relates to the use of gTso thal in the production of a medicament that significantly increases the ability of MS-275 to penetrate the blood-brain barrier and accumulate in brain tissue. The administration of this medicament in combination with MS-275 has shown promising results in enhancing drug delivery to the brain.

Career Highlights

Wenjing Jia is affiliated with the Chinese Academy of Sciences, where he conducts research and development in pharmaceutical sciences. His work focuses on innovative solutions to improve drug efficacy and delivery mechanisms.

Collaborations

Wenjing has collaborated with notable colleagues, including Ting Ting Zhang and Xiaohui Zhao, who contribute to his research endeavors.

Conclusion

Wenjing Jia's innovative work in pharmaceutical preparations exemplifies the potential for advancements in drug delivery systems. His contributions are paving the way for more effective treatments for conditions requiring targeted brain therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…